<DOC>
	<DOCNO>NCT02848196</DOCNO>
	<brief_summary>The study design assess efficacy ablative SBRT deliver VMAT technique oligometastatic patient affect adrenal gland metastasis .</brief_summary>
	<brief_title>An Image-guided SBRT Adrenal Gland Metastasis Oligometastatic Patients</brief_title>
	<detailed_description>This phase II , single arm , trial test efficacy ablative high hypofractionated dose deliver VMAT technique oligometastatic patient adrenal gland metastasis . The potential advantage approach include possibility lead increase local control irradiate adrenal gland metastasis . Other purpose study assess acute late toxicity term maintenance endocrine mechanisms hormonal production .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Adrenal Gland Neoplasms</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Age ≥ 18years . WHO performance status ≤ 1 ( ECOG KPS ) . Histologicallyproven primary cancer disease Metastases adrenal gland radiologically proven Written inform consent Prior radiation interested adrenal gland . Patients allergic contrast use CT scan premedicated use contrast .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>